Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies
Public ClinicalTrials.gov record NCT06486428. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Study to Evaluate a Remote, Decentralized, Direct-to-Patient Strategy for Clinical Research Engagement of Patients With Small Cell Lung Cancer (SCLC).
Study identification
- NCT ID
- NCT06486428
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 30 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 22, 2025
- Primary completion
- Nov 30, 2026
- Completion
- May 31, 2027
- Last update posted
- Jul 31, 2025
2025 – 2027
United States locations
- U.S. sites
- 52
- U.S. states
- 51
- U.S. cities
- 52
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Alabama | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Alaska | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Arizona | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Arkansas | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | California | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Colorado | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Connecticut | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Delaware | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | District of Columbia | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Florida | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Georgia | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Hawaii | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Idaho | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Illinois | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Indiana | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Iowa | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Kansas | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Kentucky | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Louisiana | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Maine | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Maryland | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Massachusetts | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Michigan | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Minnesota | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Mississippi | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Missouri | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Montana | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Nebraska | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Nevada | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | New Hampshire | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | New Jersey | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | New Mexico | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | New York | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | North Carolina | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | North Dakota | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Ohio | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Oklahoma | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Oregon | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Pennsylvania | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Rhode Island | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | South Carolina | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | South Dakota | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Tennessee | 37232 | Recruiting |
| Vanderbilt-Ingram Cancer Center | Nashville | Tennessee | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Texas | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Utah | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Vermont | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Virginia | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Washington | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | West Virginia | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Wisconsin | 37232 | Recruiting |
| Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html | Multiple Locations | Wyoming | 37232 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Small-cell Lung Cancer trials
Other public records listing Small-cell Lung Cancer. Sorted by last update posted; newest first. Not a recommendation.
- NCT01064466: Pharmacogenomics ANDA SNP Clinical Study - Etoposide and Single Nucleotide Polymorphisms Active, not recruiting
- NCT07783477: A Study of Armored CAR T Cells in People With Cancer Not yet recruiting
- NCT07778316: Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC) Recruiting
- NCT04199741: PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56 Recruiting
- NCT07365241: A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer Recruiting
- NCT07707895: DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers Not yet recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06486428, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 31, 2025 · Synced Apr 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06486428 live on ClinicalTrials.gov.